Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07332741 · ClinicalTrials.gov registry record · Phase 2
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
A Phase 2 study, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT07332741 is a Phase 2 study that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 150 participants.
The verdict
NCT07332741, a Phase 2 study, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?
Interventions
- COMBINATION_PRODUCT FIM intervention arm
- COMBINATION_PRODUCT FIM Usual Care Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-05-22 |
| Est. Completion | 2030-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07332741
The ClinicalTrials.gov registry entry for NCT07332741 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FIM intervention arm is the first listed.
NCT07332741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07332741 about?
NCT07332741 is a clinical study titled "FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control". The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and lever...
What is the current status of trial NCT07332741?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2026-05-22. Estimated completion is 2030-09.
What interventions are being tested in trial NCT07332741?
The interventions under investigation include: FIM intervention arm (COMBINATION_PRODUCT), FIM Usual Care Arm (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07332741?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.